| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |